Encompass Health (NYSE:EHC – Get Free Report) had its price target raised by research analysts at Mizuho from $77.00 to $82.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the stock. Mizuho’s price objective would indicate a potential upside of 12.85% from the company’s current price. […]